세계의 철 결핍증 주사제 시장 보고서(2025년)

Iron deficiency refers to a condition where the body lacks adequate iron, leading to decreased production of red blood cells and hemoglobin. Iron deficiency injectables refer to injectable medications or solutions used to treat iron deficiency. These injectable forms of iron allow for direct delivery of the iron into the bloodstream, bypassing the digestive system.

The main types of iron deficiency injectables are iron dextran, iron sucrose and ferric carboxymaltose. Iron dextran is a complex of iron and a carbohydrate called dextran. The various types of branded or generics are branded, generics that are used in various applications such as chronic kidney disease, inflammatory bowel disease, cancer and others and also by various end users such as hospitals, homecare, specialty clinics and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The iron deficiency injectables market research report is one of a series of new reports from The Business Research Company that provides iron deficiency injectables market statistics, including iron deficiency injectables industry global market size, regional shares, competitors with an iron deficiency injectables market share, detailed iron deficiency injectables market segments, market trends and opportunities and any further data you may need to thrive in the iron deficiency injectables industry. This iron deficiency injectables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iron deficiency injectable market size has grown strongly in recent years. It will grow from $14.06 billion in 2024 to $15.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to high prevalence of iron deficiency anemia treatments, bariatric surgery patients, pediatric and adolescent patients, growing pregnancy.

The iron deficiency injectable market size is expected to see rapid growth in the next few years. It will grow to $22.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to geriatric population, global health initiatives, government initiatives, incresing treatments for chronic conditions, rapid iron replenishment. Major trends in the forecast period include advances in iron formulations, digital health solutions, advancements in iron deficiency injectable therapy, adoption of iron-based drugs.

The forecast of 10.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. healthcare by increasing costs for intravenous iron formulations sourced from Switzerland and Austria, potentially compromising treatment for severe anemia and raising infusion center operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The iron deficiency injectables market is anticipated to experience growth due to the increasing prevalence of polycystic ovary syndrome (PCOS). PCOS is a commonly occurring hormonal disorder that predominantly affects individuals with ovaries, primarily women in their reproductive years. PCOS often leads to iron overload, resulting in excessive menstrual bleeding and subsequent anemia in affected patients. Injectable iron deficiency medications offer an effective solution to address this condition. For example, as of June 2023, the World Health Organization, a specialized health agency based in the United States, estimates that PCOS affects approximately 8-13% of reproductive-aged women globally, with 70% of cases remaining undiagnosed. Hence, the rising prevalence of polycystic ovary syndrome (PCOS) serves as a driving force behind the growth of the iron deficiency injectables market.

The substantial prevalence of malnutrition is a key driver behind the expansion of the iron deficiency injectable market. Malnutrition signifies a health condition marked by an imbalance between the intake of essential nutrients and the nutritional requirements of the body. Iron deficiency injectables play a crucial role in addressing malnutrition by swiftly replenishing iron stores and delivering a concentrated dose of iron that is readily absorbed into the bloodstream, enabling the rapid correction of the deficiency. For example, in March 2023, the California Department of Public Health reported an increase in malnutrition-related deaths to 1,406 in 2022, marking a notable 22.36% surge compared to the 1,149 deaths recorded in 2021. As a result, the heightened prevalence of malnutrition is expected to drive the future growth of the iron deficiency injectable market.

Prominent companies operating in the iron deficiency injectables market are actively engaged in the development of innovative therapies, such as INJECTAFER, to maintain their competitive standing in the market. For instance, in June 2023, Daiichi Sankyo Company, a U.S.-based healthcare company, in collaboration with American Regent Inc., a U.S.-based injectables manufacturer, introduced INJECTAFER (ferric carboxymaltose injection) for the treatment of iron deficiency. This innovative therapy received approval from the Food and Drug Administration (FDA), a U.S. government agency. INJECTAFER is recognized as the first and only intravenous iron replacement therapy approved for adult patients with chronic and progressive heart failure. It has undergone rigorous evaluation through more than 40 clinical trials involving over 8,800 participants from various countries, demonstrating its effectiveness in patients, including adults and pediatric individuals with iron-deficient anemia and heart failure.

In August 2022, CSL Limited, an Australian-based biotechnology company specializing in the production of iron deficiency injectables, completed the acquisition of Vifor Pharma for an undisclosed sum. This strategic acquisition reinforces CSL's commitment to patient care and enhances its capability to provide advanced medications. Vifor Pharma, headquartered in Switzerland, is a pharmaceutical company renowned for its offerings in the field of iron deficiency injectables.

Major companies operating in the iron deficiency injectable market are Daiichi Sankyo Company Limited, Pfizer Inc., Aetna Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, GSK PLC, Fresenius Medical Care, Teva Pharmaceutical Industries Ltd., Mylan N.V., B Braun Medical Inc., Sandoz, Fresenius Kabi AG, Cipla Limited, Emcure Pharmaceuticals Ltd., AMAG Pharmaceuticals Inc., Luitpold Pharmaceuticals Inc., Akebia Therapeutics Inc., Covis Pharma GmbH, Keryx Biopharmaceuticals Inc., Rockwell Medical Inc., American Regent Inc., Galen Medical Group.

North America was the largest region in the iron deficiency injectable market in 2024. The regions covered in iron deficiency injectable report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iron deficiency injectable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The iron deficiency injectable market consists of sales of ferumoxide, sodium ferric gluconate and iron gluconate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iron Deficiency Injectable Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iron deficiency injectable market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for iron deficiency injectable ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The iron deficiency injectable market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Iron Dextran; Iron Sucrose; Ferric Carboxymaltose
• 2) By Branded or Generics: Branded; Generics
• 3) By Application: Chronic Kidney Disease; Inflammatory Bowel Disease; Cancer; Other Applications
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Iron Dextran: Low Molecular Weight Iron Dextran; High Molecular Weight Iron Dextran
• 2) By Iron Sucrose: Venofer
• 3) By Ferric Carboxymaltose: Injectafer; Ferinject
• Companies Mentioned: Daiichi Sankyo Company Limited; Pfizer Inc.; Aetna Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A; AstraZeneca Plc; GSK Plc; Fresenius Medical Care; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; B Braun Medical Inc.; Sandoz; Fresenius Kabi AG; Cipla Limited; Emcure Pharmaceuticals Ltd.; AMAG Pharmaceuticals Inc.; Luitpold Pharmaceuticals Inc.; Akebia Therapeutics Inc.; Covis Pharma GmbH ; Keryx Biopharmaceuticals Inc.; Rockwell Medical Inc.; American Regent Inc.; Galen Medical Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Iron Deficiency Injectable Market Characteristics

3. Iron Deficiency Injectable Market Trends And Strategies

4. Iron Deficiency Injectable Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Iron Deficiency Injectable Growth Analysis And Strategic Analysis Framework

• 5.1. Global Iron Deficiency Injectable PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Iron Deficiency Injectable Market Growth Rate Analysis
• 5.4. Global Iron Deficiency Injectable Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Iron Deficiency Injectable Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Iron Deficiency Injectable Total Addressable Market (TAM)

6. Iron Deficiency Injectable Market Segmentation

• 6.1. Global Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iron Dextran
• Iron Sucrose
• Ferric Carboxymaltose
• 6.2. Global Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Branded
• Generics
• 6.3. Global Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Kidney Disease
• Inflammatory Bowel Disease
• Cancer
• Other Applications
• 6.4. Global Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.5. Global Iron Deficiency Injectable Market, Sub-Segmentation Of Iron Dextran, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low Molecular Weight Iron Dextran
• High Molecular Weight Iron Dextran
• 6.6. Global Iron Deficiency Injectable Market, Sub-Segmentation Of Iron Sucrose, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Venofer
• 6.7. Global Iron Deficiency Injectable Market, Sub-Segmentation Of Ferric Carboxymaltose, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectafer
• Ferinject

7. Iron Deficiency Injectable Market Regional And Country Analysis

• 7.1. Global Iron Deficiency Injectable Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Iron Deficiency Injectable Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Iron Deficiency Injectable Market

• 8.1. Asia-Pacific Iron Deficiency Injectable Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Iron Deficiency Injectable Market

• 9.1. China Iron Deficiency Injectable Market Overview
• 9.2. China Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Iron Deficiency Injectable Market

• 10.1. India Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Iron Deficiency Injectable Market

• 11.1. Japan Iron Deficiency Injectable Market Overview
• 11.2. Japan Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Iron Deficiency Injectable Market

• 12.1. Australia Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Iron Deficiency Injectable Market

• 13.1. Indonesia Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Iron Deficiency Injectable Market

• 14.1. South Korea Iron Deficiency Injectable Market Overview
• 14.2. South Korea Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Iron Deficiency Injectable Market

• 15.1. Western Europe Iron Deficiency Injectable Market Overview
• 15.2. Western Europe Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Iron Deficiency Injectable Market

• 16.1. UK Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Iron Deficiency Injectable Market

• 17.1. Germany Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Iron Deficiency Injectable Market

• 18.1. France Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Iron Deficiency Injectable Market

• 19.1. Italy Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Iron Deficiency Injectable Market

• 20.1. Spain Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Iron Deficiency Injectable Market

• 21.1. Eastern Europe Iron Deficiency Injectable Market Overview
• 21.2. Eastern Europe Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Iron Deficiency Injectable Market

• 22.1. Russia Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Iron Deficiency Injectable Market

• 23.1. North America Iron Deficiency Injectable Market Overview
• 23.2. North America Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Iron Deficiency Injectable Market

• 24.1. USA Iron Deficiency Injectable Market Overview
• 24.2. USA Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Iron Deficiency Injectable Market

• 25.1. Canada Iron Deficiency Injectable Market Overview
• 25.2. Canada Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Iron Deficiency Injectable Market

• 26.1. South America Iron Deficiency Injectable Market Overview
• 26.2. South America Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Iron Deficiency Injectable Market

• 27.1. Brazil Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Iron Deficiency Injectable Market

• 28.1. Middle East Iron Deficiency Injectable Market Overview
• 28.2. Middle East Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Iron Deficiency Injectable Market

• 29.1. Africa Iron Deficiency Injectable Market Overview
• 29.2. Africa Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Iron Deficiency Injectable Market Competitive Landscape And Company Profiles

• 30.1. Iron Deficiency Injectable Market Competitive Landscape
• 30.2. Iron Deficiency Injectable Market Company Profiles
  • 30.2.1. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Iron Deficiency Injectable Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A
• 31.3. AstraZeneca Plc
• 31.4. GSK Plc
• 31.5. Fresenius Medical Care
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Mylan N.V.
• 31.8. B Braun Medical Inc.
• 31.9. Sandoz
• 31.10. Fresenius Kabi AG
• 31.11. Cipla Limited
• 31.12. Emcure Pharmaceuticals Ltd.
• 31.13. AMAG Pharmaceuticals Inc.
• 31.14. Luitpold Pharmaceuticals Inc.
• 31.15. Akebia Therapeutics Inc.

32. Global Iron Deficiency Injectable Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Iron Deficiency Injectable Market

34. Recent Developments In The Iron Deficiency Injectable Market

35. Iron Deficiency Injectable Market High Potential Countries, Segments and Strategies

• 35.1 Iron Deficiency Injectable Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Iron Deficiency Injectable Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Iron Deficiency Injectable Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer